BR0117149A - Uso de um copolìmero para produzir uma forma farmacêutica contendo um peptìdio ou proteìna como agente ativo - Google Patents

Uso de um copolìmero para produzir uma forma farmacêutica contendo um peptìdio ou proteìna como agente ativo

Info

Publication number
BR0117149A
BR0117149A BR0117149-6A BR0117149A BR0117149A BR 0117149 A BR0117149 A BR 0117149A BR 0117149 A BR0117149 A BR 0117149A BR 0117149 A BR0117149 A BR 0117149A
Authority
BR
Brazil
Prior art keywords
peptide
copolymer
protein
pharmaceutical form
produce
Prior art date
Application number
BR0117149-6A
Other languages
English (en)
Inventor
Hans-Ulrich Petereit
Thomas Beckert
Original Assignee
R Ehm Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Ehm Gmbh & Co Kg filed Critical R Ehm Gmbh & Co Kg
Publication of BR0117149A publication Critical patent/BR0117149A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"USO DE UM COPOLìMERO PARA PRODUZIR UMA FORMA FARMACêUTICA CONTENDO UM PEPTìDIO OU PROTEìNA COMO AGENTE ATIVO". A presente invenção concerne o uso de um copolímero ou uma mistura de copolímeros, consistindo em ésteres C~ 1-4~ alquílicos de ácido acrílico ou metacrílico, contendo individualmente ou em mistura 5 a 25% em peso de ácido metacrílico como agente de revestimento de uma forma farmacêutica que consiste em um núcleo que inclui um agente farmacêutico ativo na forma de peptídio ou de proteína. A invenção também concerne a forma farmacêutica resultante.
BR0117149-6A 2001-10-15 2001-10-15 Uso de um copolìmero para produzir uma forma farmacêutica contendo um peptìdio ou proteìna como agente ativo BR0117149A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2001/011899 WO2003032958A1 (de) 2001-10-15 2001-10-15 Verwendung eines copolymeren zur herstellung einer arzneiform, die als wirkstoff ein peptid oder protein enthält

Publications (1)

Publication Number Publication Date
BR0117149A true BR0117149A (pt) 2004-11-23

Family

ID=8164626

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0117149-6A BR0117149A (pt) 2001-10-15 2001-10-15 Uso de um copolìmero para produzir uma forma farmacêutica contendo um peptìdio ou proteìna como agente ativo

Country Status (12)

Country Link
US (1) US20030091637A1 (pt)
EP (1) EP1435922A1 (pt)
JP (1) JP2005506991A (pt)
KR (1) KR20040047915A (pt)
BR (1) BR0117149A (pt)
CA (1) CA2460132A1 (pt)
HU (1) HUP0401732A2 (pt)
IL (1) IL160190A0 (pt)
MX (1) MXPA04003540A (pt)
PL (1) PL367957A1 (pt)
SK (1) SK1732004A3 (pt)
WO (1) WO2003032958A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04010956A (es) * 2003-01-30 2005-01-25 Roehm Gmbh Forma de dosis farmaceutica y metodo para la produccion de la misma.
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
DE10332160A1 (de) * 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
DE60301351T2 (de) 2003-07-25 2006-01-19 Ferring B.V. Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung
CN1826099B (zh) * 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
CA2490601C (en) * 2003-12-29 2006-05-02 Ferring B.V. Method for preparing solid dosage form of desmopressin
EP1550439B1 (en) * 2003-12-29 2006-03-08 Ferring B.V. Method for preparing a solid dosage form of desmopressin
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
PL1883396T3 (pl) 2005-05-18 2014-03-31 Da Volterra Dostarczanie adsorbentów do okrężnicy
DE102005024614A1 (de) * 2005-05-25 2006-11-30 Röhm Gmbh Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug
US8048413B2 (en) 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
JP5524624B2 (ja) * 2007-11-16 2014-06-18 旭化成ケミカルズ株式会社 水系フィルムコーティング液、および、フィルムコーティング顆粒、ならびに、これを用いた錠剤
EP3250191B1 (en) * 2015-01-29 2024-01-17 Novo Nordisk A/S Tablets comprising glp-1 agonist and enteric coating

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208465A (en) * 1978-05-03 1980-06-17 E. I. Du Pont De Nemours And Company Clear coat/color coat finish containing an antioxidant and an ultraviolet light stabilizer
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3405378A1 (de) * 1984-02-15 1985-08-22 Röhm GmbH, 6100 Darmstadt Arzneimittelueberzug
DE3524337A1 (de) * 1985-07-08 1987-01-08 Roehm Gmbh Arzneimittelumhuellung
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US5032405A (en) * 1989-09-27 1991-07-16 Warner-Lambert Company Oral pharmaceutical composition for acid sensitive proteinaceous agents
DE4026992A1 (de) * 1990-08-25 1992-02-27 Roehm Gmbh Verfahren zur herstellung von traegersystemen fuer biologisch aktive materialien
AU664561B2 (en) * 1991-06-21 1995-11-23 University Of Cincinnati, The Orally administrable therapeutic proteins and method of making
DK0603992T4 (da) * 1992-12-22 2001-03-05 Univ Cincinnati Oral indgivelse af immunologisk aktive biomolekyler og andre terapeutiske proteiner
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
DE9414065U1 (de) * 1994-08-31 1994-11-03 Roehm Gmbh Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
DE9414066U1 (de) * 1994-08-31 1994-11-03 Roehm Gmbh Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
DE19653606A1 (de) * 1996-12-20 1998-06-25 Roehm Gmbh Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
DE19715794C1 (de) * 1997-04-16 1998-12-03 Roehm Gmbh Laminare Arzneiform und Verfahren zu ihrer Herstellung
EP1244468A2 (en) * 2000-01-07 2002-10-02 University Of Cincinnati Selective activation of a th1 or th2 lymphocyte regulated immune response

Also Published As

Publication number Publication date
WO2003032958A1 (de) 2003-04-24
HUP0401732A2 (hu) 2004-12-28
CA2460132A1 (en) 2003-04-24
SK1732004A3 (sk) 2005-06-02
JP2005506991A (ja) 2005-03-10
IL160190A0 (en) 2004-07-25
MXPA04003540A (es) 2004-07-22
EP1435922A1 (de) 2004-07-14
PL367957A1 (en) 2005-03-07
US20030091637A1 (en) 2003-05-15
KR20040047915A (ko) 2004-06-05

Similar Documents

Publication Publication Date Title
BR0117149A (pt) Uso de um copolìmero para produzir uma forma farmacêutica contendo um peptìdio ou proteìna como agente ativo
BR0208183A (pt) Peptìdeo modificado por wt1
BR0114713A (pt) Formulação lipossÈmica de mitoxantrona
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
NO20034323L (no) Medisinske aerosolformuleringer
BR0313197A (pt) Agentes citotóxicos contendo potentes taxanos e seu uso terapêutico
ES2155043B1 (es) Composiciones farmaceuticas comprendiendo acido pirimidin-5-il(3r, 5s)-3,5-dihidroxihept-6-enoico o una sal suya, su estabilizacion con sal fosfato tribasico y su preparacion.
BR0311877A (pt) Preparações ácidas de insulina com estabilidade aperfeiçoada
WO2003099830A3 (en) Cardiolipin compositions, methods of preparation and use
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
BR0011347A (pt) Preparações e formas de administração compreendendo um composto ativo de ácido instável
BRPI0516077A (pt) composições antimicrobianas compreendendo um agente natural selecionado de ácido gálico, eucalipotol, naringina, um composto de ácido jasmÈnico e qualquer combinação destes
BRPI0316532B8 (pt) composições farmacêuticas compreendendo uma droga básica ou ácida, um tensoativo, e um ácido ou base solúvel em água fisiologicamente tolerável
BRPI0514411B8 (pt) formulação, e, método de produzir uma formulação
BRPI0017528B8 (pt) uso de uma composição contendo sal de cetotifeno
BR0317395A (pt) Sìlica estruturalmente modificada
BR9812718A (pt) Uso de pelo menos 0,5%, em peso, de água como um aditivo em uma composição de vaporizador para cabelo, e, composição de vaporizador para cabelo
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами
BRPI0412697A (pt) composições farmacêuticas que apresentam um revestimento expansìvel
BR0107262C1 (pt) Composição a base de monoterpenos, com efeito, quimiopreventivo e quimioterápico em neoplasias malignas de seres humanos e animais, utilização dos monoterpenos na inbição do crescimento de células tumorais e no controle de metástases de tumores primários e método especìfico de utilização da composição, com efeito, quimiopreventivo e quimioterápico em seres humanos e animais
BR0109139A (pt) Composições farmacêuticas incluindo alginatos
BR0009194A (pt) Composição do resorcinol
BR0215306A (pt) Uso de deoxipeganina
Pohanka et al. Sulfur mustard induced oxidative stress and its alteration using asoxime (HI-6)
BR0210063A (pt) Composição estável e uso da mesma

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]